Studies have shown that mTORC1 is involved in the mTOR/SREBP-1c/FASN pathway, which is a key pathway involved in regulation of cellular lipid metabolism and is closely associated with the development of NAFLD (Yi et al., 2020). This evidence concerns the gene SREBF1 and metabolic dysfunction-associated steatotic liver disease.